David Fisher
Family Medicine · Columbia, SCNPI 1629088299
Payments from drug & device makers
Across 109 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$241
- AstraZeneca$155
- Novo Nordisk$141
- Takeda Pharmaceuticals U.S.A., Inc.$72
- Sunovion Pharmaceuticals Inc.$69
- Esperion Therapeutics, Inc.$53
- plus $863 from 30 others
What the payments were for
- Food & beverage$1,58199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $241 |
| AstraZeneca | 11 | $155 |
| Novo Nordisk | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 4 | $69 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| Lilly USA, LLC | 4 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Pfizer | 3 | $50 |
| Corcept Therapeutics | 3 | $47 |
| Amarin Pharma, Inc. | 3 | $44 |
| Merck | 3 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $39 |
| Clarus Therapeutics Inc. | 3 | $38 |
| Abbott | 2 | $35 |
| Genentech USA, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $35 |
| Nabriva Therapeutics, PLC | 2 | $34 |
| Amgen | 2 | $30 |
| Novartis | 2 | $28 |
| Gilead | 1 | $25 |
| Briohealth Solutions, Inc. | 1 | $25 |
| Medtronic | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Boston Scientific | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Bayer | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,593 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Icosapent Ethyl | 11 | $2,194 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Columbia
- Conigliaro JonesColumbia$552K
- Damon DanielsColumbia$300K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Terry NagelColumbia$112K
- Steven BarnettColumbia$33K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.